Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07287215

Motor Imagery and Functional Performance in Diplegic Cerebral Palsy

Investigation of the Relationship Between Motor Imagery Ability and Functional Mobility, Walking, and Balance in Children With Diplegic Cerebral Palsy

Status
Recruiting
Phase
Study type
Observational
Enrollment
99 (estimated)
Sponsor
Inonu University · Academic / Other
Sex
All
Age
5 Years – 18 Years
Healthy volunteers
Accepted

Summary

The main purpose of this study was to examine the relationship between motor imagery capacity and functional mobility, walking and balance in children with diplegic type cerebral palsy.

Detailed description

This study will be conducted using a cross-sectional and correlational screening model to examine the relationship between motor imagery ability and functional mobility, walking, and balance in children with diplegic cerebral palsy. Data collection will be conducted through one-on-one assessments after obtaining written consent from volunteer participants and their families. The data collection tools used in the study are listed below: Demographic Information Form, Motor Imagery Ability Assessment, Mental Stopwatch Paradigm, Functional Mobility, and Gait Assessment.

Conditions

Interventions

TypeNameDescription
OTHERMotor Imagery Ability AssessmentLaterality Task (Choice Task): Implicit Motor Imagery capacity will be measured through a laterality task, which involves deciding which side a limb belongs to. Right-left discrimination of the foot will be assessed using the "Recognize Foot" application developed by the Neuro Orthopaedic Institute
OTHERMental Stopwatch ParadigmA mental stopwatch will be used to assess explicit MI capacity. This paradigm compares the time between the actual movement duration and the duration of a similar imagined task.
OTHERFunctional MobilityFunctional Mobility: Functional Mobility will be assessed using the Functional Mobility Scale (FMS) and the Timed Up and Go test.
OTHERGait assessment:Gait assessment: The Gillette FDA is a self- or observer-based assessment tool.

Timeline

Start date
2025-11-24
Primary completion
2026-02-23
Completion
2026-02-26
First posted
2025-12-17
Last updated
2025-12-17

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07287215. Inclusion in this directory is not an endorsement.